Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 147-153

  Nakeeb, Attila ^a   Lipsett, Pamela A ^a   Lillemoe, Keith D ^a   Fox Talbot, Mary K ^a   Coleman, JoAnn ^a   Cameron, John L ^a   Pitt, Henry A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Blalock 679 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; BILE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CHOLELITHIASIS; CLINICAL ARTICLE; COMMON BILE DUCT CYST; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; GALLSTONE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; STENT;

ADULT; AGED; BILE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOEMBRYONIC ANTIGEN; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CHOLEDOCHAL CYST; CHOLELITHIASIS; CHOLESTASIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIDDLE AGED;

EID: 0030033366     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80090-7     Document Type: Article

References (21)

1. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg. 1995;32:1-100.
2. Langer JC, Langer B, Taylor BR, et al. Carcinoma of the extra-hepatic bile ducts: results of an aggressive surgical approach. Surgery. 1985;98:752-759.
3. Desa LA, Akosa AB, Lazzara S, et al. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut. 1991;32:1188-1191.
4. Tsutsumi Y, Nagura H, Watanabe K. Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas. Am J Clin Pathol. 1984;82: 535-542.
5. Maxwell P, Davis RI, Sloan JM. Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. J Pathol. 1993;170:73-76.
6. Nakajima T, Kondo Y. Well-differentiated cholangiocarcinoma: diagnostic significance of morphological and immunohistochemical parameters. Am J Surg Pathol. 1989;13:569-573.
7. Tatsuta M, Itoh T, Okuda S, et al. Carcinoembryonic antigen in gastric juice as an aid in diagnosis of early gastric cancer. Cancer. 1980; 46:2686-2692.
8. Tatsuta M, Iishi H, Ichii M, et al. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer. 1986;57:1836-1839.
9. Yeatman TJ, Bland KI, Copeland EM, et al. Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg. 1989;210:505-512.
10. Tatsuta M, Yamamura H, Yamamoto R, et al. Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Cancer. 1982;20:2903-2909.
11. Uchino R, Kanemitsu K, Obayashi H, et al. Carcinoembryonic antigen (CEA) and CEA-related substances in the bile of patients with biliary diseases. Am J Surg. 1994;167:306-308.
12. Yeatman TJ, Kimura AK, Copeland EM, Bland KI. Rapid analysis of carcinoembryonic antigen levels in gallbladder bile. Ann Surg. 1991;213:113-117.
13. Rosen CB, Nagorney DM, Weisner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991; 213:21-25.
14. Farrant JM, Haylarr KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991;100:1710-1717.
15. Todani T, Tabuchi K, Watanabe Y, et al. Carcinoma arising in the wall of congenital bile duct cysts. Cancer. 1979;44:1134-1139.
16. Sheen-Chen SM, Chou FF, Eng HL. Intrahepatic cholangiocarcinoma in hepatolithiasis: a frequently overlooked disease. J Surg Oncol. 1991;47:131-135.
17. Looser CH, Stain SC, Baer HU, et al. Staging of hilar cholangiocarcinoma by ultrasound and duplex sonography: a comparison with angiography and preoperative findings. Br J Radiol. 1992;65:871-877.
18. Yamashita Y, Takahahi M, Kanazawa S, et al. Parenchymal changes of the liver in cholangiocarcinoma: CT evaluation. Gastrointest Radiol. 1992;17:161-166.
19. Pasanen PA, Eskelinen M, Partanen K, et al. Clinical value of serum tumor markers CEA, CA 50, CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: results from a prospective study. Anticancer Res. 1992;12: 1689-1694.
20. Ohshio G, Manabe T, Watanabe Y, et al. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. Am J Gostroenterol. 1990;85: 1370-1376.
21. Ramage JK, Donaghy A, Farrant MJ, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108:865-869.